NasdaqGS - Delayed Quote USD
Arbutus Biopharma Corporation (ABUS)
3.3400
+0.1000
+(3.09%)
At close: April 24 at 4:00:00 PM EDT
3.3200
-0.02
(-0.60%)
After hours: April 24 at 7:00:41 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
131,707
144,401
195,419
204,485
Total Liabilities Net Minority Interest
34,341
38,383
58,567
35,046
Total Equity Gross Minority Interest
97,366
106,018
136,852
169,439
Total Capitalization
97,366
106,018
136,852
169,439
Common Stock Equity
97,366
106,018
136,852
169,439
Capital Lease Obligations
1,289
1,768
2,187
2,614
Net Tangible Assets
97,366
106,018
136,852
169,439
Working Capital
111,698
109,540
118,282
149,440
Invested Capital
97,366
106,018
136,852
169,439
Tangible Book Value
97,366
106,018
136,852
169,439
Total Debt
1,289
1,768
2,187
2,614
Share Issued
189,963.4920
169,867.4140
157,455.3630
144,987.7360
Ordinary Shares Number
189,963.4920
169,867.4140
157,455.3630
144,987.7360
12/31/2021 - 7/26/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROIV Roivant Sciences Ltd.
11.00
+2.42%
ARWR Arrowhead Pharmaceuticals, Inc.
13.34
+2.54%
IMVT Immunovant, Inc.
15.07
+4.29%
FOLD Amicus Therapeutics, Inc.
7.20
+1.41%
MREO Mereo BioPharma Group plc
2.5400
-0.78%
CVAC CureVac N.V.
3.2600
+2.84%
RIGL Rigel Pharmaceuticals, Inc.
19.06
+4.96%
PRAX Praxis Precision Medicines, Inc.
36.00
-1.61%
SWTX SpringWorks Therapeutics, Inc.
44.93
+9.03%
CLDX Celldex Therapeutics, Inc.
19.58
+0.77%